close
close

Gritstone bio, inc. Investors: Class action lawsuit filed

Investors can contact law firm for free to learn more about recovering losses

LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) — Portnoy Law Firm informs investors of Gritstone bio, Inc. (“Gritstone” or the “Company”) (NASDAQ: GRTS) to file a class action lawsuit on behalf of investors. We encourage Gritstone investors who have lost money on their investment to contact Lesley Portnoy, Esq.

Investors who purchased and/or sold shares between March 9, 2023 and February 29, 2024 are encouraged to contact attorney Lesley F. Portnoy at 310-692-8883 or lesley @portnoylaw.com to discuss your rights, or click here to join the case via www.portnoylaw.com. Portnoy Law Firm can evaluate your case free of charge and discuss investors’ options for pursuing claims to recover their losses.

The complaint alleges that the Company made false and misleading statements to the market. Gritstone will not launch the Phase 2b CORAL study on the date promised to investors. This delay made it difficult for the Company to obtain external financing for the study. The company overestimated its ability to commercialize its products. Based on these facts, the Company’s public statements were false and materially misleading throughout the audit period. When the market learned the truth about Gritstone, investors suffered losses.

Please visit our website for additional information and to submit your transaction details.

Portnoy Law Firm represents investors in pursuing claims resulting from corporate irregularities. The company’s founding partner recovered over $5.5 billion for injured investors. Attorney advertising. Past performance does not guarantee similar results.

Lesley F. Portnoy, Esq.
Admitted to the bar in California and New York
[email protected]
310-692-8883
www.portnoylaw.com
Lawyer advertising